Alicia O'Neill (@patients1staon) 's Twitter Profile
Alicia O'Neill

@patients1staon

Director Patient Advocacy, Oncology, GSK; Following cancer advocates, KOLs. Keeping up on news to help patients. Views expressed here are my own not employer

ID: 180430451

linkhttps://gsk.com calendar_today19-08-2010 16:31:43

351 Tweet

245 Followers

302 Following

Vincent Rajkumar (@vincentrk) 's Twitter Profile Photo

7. Masks Universal masking when going out helps prevent because 40% spread is from asymptomatic people. No side effects. Prevents you from spreading. May also protect you some. #Masks4All Cloth masks enough. Jeremy Howard Siddhartha Mukherjee Anna Kaltenboeck tinyurl.com/yage6zgd

Vincent Rajkumar (@vincentrk) 's Twitter Profile Photo

8. Antiviral with high efficacy We don’t have one yet. This will be a game changer. Many promising ones are in clinical trials. Remdesivir data leaks are unfortunate, but show it may not be the answer. Matthew Herper

Daniel Auclair (@auclairdan) 's Twitter Profile Photo

12-0 vote from ⁦FDA Oncology⁩ ODAC panel in favor of ⁦GSK⁩ belantamab mafodotin for relapsed/refractory #myeloma #mmsm ⁦Sagar Lonial MD⁩ onclive.com/view/fda-panel…

Suzanne Lentzsch, MD, PhD (@slentzsch) 's Twitter Profile Photo

#iwMyeloma20 Excellent presentation by Dr Trudel from Princess Margaret Cancer Centre Keith Stewart. She pointed out that Belamaf causes symptomatic keratopathy due to micro cyst in 52%. Keratopathy is reversible! Should be monitored by ophthalmology. #mmsm VJHemOnc

#iwMyeloma20 Excellent presentation by Dr Trudel from <a href="/pmcancercentre/">Princess Margaret Cancer Centre</a> <a href="/akeithstewart/">Keith Stewart</a>. She pointed out that Belamaf causes symptomatic keratopathy due to micro cyst in 52%. Keratopathy is reversible! Should be monitored by ophthalmology. #mmsm <a href="/VJHemOnc/">VJHemOnc</a>
Multiple Myeloma RF (@themmrf) 's Twitter Profile Photo

Our very own Mary DeRome (Mary DeRome) was recently featured on the inaugural episode of Science on the Sofa. Learn more about the RightTrack approach and how it can benefit myeloma patients.

Naveen Pemmaraju, MD (@doctorpemm) 's Twitter Profile Photo

Awesome talk on MPN guidelines and approaches by Dr Gaby Hobbs Gaby Hobbs at our #MPNHz22 meeting in Netanya Israel 🇮🇱 !! 👏🏽 || #MPNSM

Awesome talk on MPN guidelines and approaches by Dr Gaby Hobbs <a href="/GabyHobbs/">Gaby Hobbs</a> at our #MPNHz22 meeting in Netanya Israel 🇮🇱 !! 👏🏽 || #MPNSM
Alicia O'Neill (@patients1staon) 's Twitter Profile Photo

So powerful to be with MPN patient advocates from around the globe and some of the the brightest minds in research in Netanya, Israel at the MPN Horizons 2022 Conference. #mpnhz22 #ambitiousforpatients

So powerful to be with MPN patient advocates from around the globe and some of the the brightest minds in research in Netanya, Israel at the MPN Horizons 2022 Conference. #mpnhz22 #ambitiousforpatients
Alicia O'Neill (@patients1staon) 's Twitter Profile Photo

To transplant or not for Myelofibrosis? Such a tough question. Today we heard the pros and cons. We heard from experts Dr Naveen Pemmaraju and Dr Martin Ellis Naveen Pemmaraju, MD #MPNHHZ22

To transplant or not for Myelofibrosis?   Such a tough question. Today we heard the pros and cons.  We heard from experts Dr Naveen Pemmaraju and Dr Martin Ellis <a href="/doctorpemm/">Naveen Pemmaraju, MD</a> #MPNHHZ22
Naveen Pemmaraju, MD (@doctorpemm) 's Twitter Profile Photo

#ASH22 #MPNSM oral session. Standing room only ! Stephen Oh kicking off session - an important dataset to discuss in our field asking the broader q what is association of BM fibrosis with other clinical parameters with #JAKi ? #BoneMarrowFibrosis ASH

#ASH22 #MPNSM oral session. Standing room only ! <a href="/mpndoc/">Stephen Oh</a> kicking off session - an important dataset to discuss in our field asking the broader q what is association of BM fibrosis with other clinical parameters with #JAKi ? #BoneMarrowFibrosis <a href="/ASH_hematology/">ASH</a>
Ruben A. Mesa, MD (@mpdrc) 's Twitter Profile Photo

👉👉👉Sartorial master & hematologist extraordinaire ⁦Aaron Gerds MD, MS⁩ presenting long term durability of efficacy seen in MOMENTUM study from momelotinib in regards to spleen reduction/symptom improvement/anemia benefit #ASH22 ⁦Naveen Pemmaraju, MD⁩ ⁦Andrew Kuykendall MD⁩ ⁦

👉👉👉Sartorial master &amp; hematologist extraordinaire ⁦<a href="/AaronGerds/">Aaron Gerds MD, MS</a>⁩ presenting long term durability of efficacy seen in MOMENTUM study from momelotinib in regards to spleen reduction/symptom improvement/anemia benefit #ASH22 ⁦<a href="/doctorpemm/">Naveen Pemmaraju, MD</a>⁩ ⁦<a href="/KuykendallMd/">Andrew Kuykendall MD</a>⁩ ⁦